iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,440.6
(-0.79%)
Aug 28, 2026|10:04:56 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
3750%₹405 0%2,000₹2 0%2,2500%
--2,060₹2.4 0%2,2500%
--2,080₹2.5 0%5,2500%
3,3750%₹277.15 0%2,100₹3 -3.22%37,500-0.99%
--2,120₹2.35 0%12,7500%
2,2500%₹282.35 0%2,140₹5.6 0%10,5000%
--2,160₹3.3 -49.23%9,0000%
3750%₹201.05 0%2,180₹7.85 0%10,5000%
52,500-4.76%₹262.2 3.47%2,200₹5.3 0%76,5000%
1,8750%₹197.15 0%2,220₹6.5 0%9,7500%
9,0000%₹179.65 0%2,240₹8.25 -6.25%37,8752.02%
15,3750%₹196.15 0%2,260₹10.3 7.85%1,64,2500.68%
13,1250%₹199.5 0%2,280₹12.9 6.17%16,875-2.17%
1,15,875-0.32%₹171.7 -3.02%2,300₹16.5 10.73%1,52,2503.83%
6,0000%₹119.85 0%2,320₹20.25 8.57%6,750-5.26%
35,6250%₹141.15 0%2,340₹23.5 3.29%17,625-6%
31,8750%₹129.1 0%2,360₹29.6 5.33%57,000-8.98%
27,7500%₹115.5 0%2,380₹36.3 7.39%32,6254.81%
3,86,2500.09%₹90.15 -9.57%2,400₹43.6 9.68%1,84,8758.35%
31,500-3.44%₹79.3 -7.3%2,420₹51.15 7.34%18,7502.04%
65,625-7.40%₹67.3 -11.5%2,440₹58.15 4.21%39,375-0.94%
70,5005.02%₹57.45 -13.02%2,460₹71.3 9.1%38,2500%
54,75010.60%₹49.35 -13.57%2,480₹119.45 0%3750%
2,33,6252.29%₹43.45 -11.77%2,500₹94.9 7.23%31,875-3.40%
3,00014.28%₹40.5 -4.7%2,520₹175.8 0%4,1250%
61,875-15.81%₹30.3 -16.29%2,540--
32,2501.17%₹24.8 -18.01%2,560₹185.1 0%1,1250%
18,000-11.11%₹21.7 -15.89%2,580--
1,50,375-24.48%₹17.4 -20.36%2,600₹154.5 0%3750%
44,2501.72%₹12.1 -22.18%2,640₹194.25 0%24,3750%
19,1258.51%₹8.7 -20.9%2,680--
58,8756.08%₹6.3 -23.17%2,720₹312.8 0%2,2500%

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.